Banner - NPPA Connect
Opinion|Videos|March 9, 2026

A PA’s Perspective on Translating CorEvitas Registry Data to the Real World

Explore the impact of patient-centered approaches in dermatology, emphasizing long-term success and quality of life in psoriasis treatment.

The CorEvitas Registry data resonates deeply with clinical experience of Physician’s Assistant (PA) Christopher Arico, confirming that patients who achieve PASI 100 (total clearance) show remarkable long-term durability, often maintaining results for many years. This evidence validates aiming for the highest targets, as clear skin strongly predicts sustained success and dramatically improves quality of life.

Experts note that real-world registry data is crucial, moving beyond clinical trial "aquariums" to show what works in diverse, everyday practice. This information creates accountability, pushing providers who may settle for lower goals to strive for complete clearance. Ultimately, the data empowers a patient-centered approach, proving that PASI 100 is not just a clinical ideal but the goal that delivers the greatest long-term happiness and stability for patients.